读了贵刊1999年第1期《肝海绵状血管瘤供血方式的临床研究》[1]一文,对其中所言及的一些问题不甚明了。为了共同提高我们对肝海绵状血管瘤(CHL)的认识,特借贵刊一角,与作者就其研究方法进行商榷。肝脏是人体唯一的双重供血器官,其中75%由肝动脉提供,其余部分来自于门静脉。在小 We read the article “Clinical Study on the Way of Blood Supply of Hepatic Cavernous Hemangioma” in the 1st issue of the Journal of China in 1999 [1], and some of the issues mentioned therein are not clear. In order to jointly improve our understanding of hepatic cavernous hemangiomas (CHL), I have borrowed the corner of your magazine and discussed with the author about his research methods. The liver is the only dual blood supply organ in the body, of which 75% is provided by the hepatic artery and the rest is from the portal vein. In small